Ryan Speer, Author at Frontier Clinical Research

TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis (UC)

TREMFYA is now FDA approved to treat Ulcerative Colitis (UC)

May 5, 2025November 4, 2024

We’re excited to announce that TREMFYA is now FDA approved to treat Ulcerative Colitis (UC)! Clinical trials were conducted at our Uniontown site, and we are incredibly grateful to all the participants who contributed to making this treatment a reality to help improve the lives of many.

New blood test for colorectal cancer screening approved by the FDA based on results of clinical study conducted at Frontier Clinical Research and other study sites across US

May 5, 2025August 14, 2024

First blood test to be approved by FDA for primary CRC screening meets performance requirements for Medicare coverage and offers a more convenient option for millions of eligible individuals.

Ryan Speer

TREMFYA is now FDA approved to treat Ulcerative Colitis (UC)

New blood test for colorectal cancer screening approved by the FDA based on results of clinical study conducted at Frontier Clinical Research and other study sites across US

Participate in Research Studies in Pennsylvania & West Virginia

Volunteer for medical research to learn more about your condition, gain access to new treatments and medications, and contribute to medical advancements.

Have a Question/Comment?

Smithfield, PA

Scottdale, PA

Uniontown, PA

Morgantown, WV (Midtown)

Morgantown, WV (Waterfront)

Kingwood, WV